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The etiology of depression is still poorly understood, but two major causative hypotheses
have been put forth: the monoamine deficiency and the stress hypotheses of depression.
We evaluate these hypotheses using animal models of endogenous depression and
chronic stress. The endogenously depressed rat and its control strain were developed by
bidirectional selective breeding from the Wistar–Kyoto (WKY) rat, an accepted model of major
depressive disorder (MDD). The WKY More Immobile (WMI) substrain shows high immobility/
despair-like behavior in the forced swim test (FST), while the control substrain, WKY Less
Immobile (WLI), shows no depressive behavior in the FST. Chronic stress responses were
investigated by using Brown Norway, Fischer 344, Lewis and WKY, genetically and
behaviorally distinct strains of rats. Animals were either not stressed (NS) or exposed to
chronic restraint stress (CRS). Genome-wide microarray analyses identified differentially
expressed genes in hippocampi and amygdalae of the endogenous depression and the
chronic stress models. No significant difference was observed in the expression of
monoaminergic transmission-related genes in either model. Furthermore, very few genes
showed overlapping changes in the WMI vs WLI and CRS vs NS comparisons, strongly
suggesting divergence between endogenous depressive behavior- and chronic stress-related
molecular mechanisms. Taken together, these results posit that although chronic stress may
induce depressive behavior, its molecular underpinnings differ from those of endogenous
depression in animals and possibly in humans, suggesting the need for different treatments.
The identification of novel endogenous depression-related and chronic stress response genes
suggests that unexplored molecular mechanisms could be targeted for the development of
novel therapeutic agents.
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Introduction
Major depressive disorder (MDD) is the third most
prevalent and costly disease worldwide, and it is
projected to become number one by 2030 (WHO, GBD
report, 2004). In addition to increasing the risk for
suicide, MDD presents frequent comorbidity with
other psychiatric disorders, and it has been identified
as a risk factor for many illnesses, including obesity,
cardiovascular, neurodegenerative and other dis-
eases.
1–4 Understanding the pathophysiology of
MDD, and providing better treatments, would im-
prove mental health and quality of life of the largest
psychiatric population in the world.
5
There are two major hypotheses with regard to the
etiology of MDD: the monoamine deficiency and
stress hypotheses of depression. The monoamine
deficiency hypothesis proposes that MDD can be
etiologically explained by a deficiency in the mono-
amine neurotransmitters serotonin, norepinephrine
and dopamine. Although this hypothesis is still
prominent and is the basis of most antidepressant
development to date, current opinion is that mono-
amine deficiency only partially explains MDD.
6–8 On
the basis of observations in MDD, the stress hypoth-
esis relates pathological alterations in the stress-
responsive hypothalamic-pituitary-adrenal (HPA)
axis to causality of depression.
9–17 Despite a large
body of data supporting a role for stress in MDD, the
nature and degree of its involvement remains un-
certain.
18 Knowing whether stress-induced depression
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endogenous depression may guide the development
of different treatment alternatives.
Animal models that reproduce key symptoms of
MDD offer a unique opportunity for experimental
exploration unfeasible in human studies.
13,14,17,19–22
Selective breeding has been used to generate animal
models of depression with extreme traits.
23–28 We
used this approach to create two substrains of the
Wistar Kyoto (WKY) rat, an accepted model of MDD
that replicates many behavioral and physiological
endophenotypes present in major depression.
29–32
The two substrains of the WKY, identified as WKY
More Immobile (WMI) and WKY Less Immobile
(WLI), were generated by bidirectional selective
breeding from the WKY based on depressive behavior
in the forced swim test (FST) of the naı ¨ve, unstressed
animals; therefore, WMIs represent an endogenous
depression model.
33 The chronic stress model em-
ployed four phylogenetically, physiologically and
behaviorally different rat strains
34,35 to identify gen-
eral, strain-independent molecular characteristics of
the chronic stress response. We chose a chronic
restraint stress (CRS) paradigm that has been shown
to increase depression-like behaviors
36–42 and reduce
hippocampal volume.
43–45
The hippocampus and amygdala were selected to
investigate gene expression profiles, as these brain
regions have been strongly implicated in the cause
and consequences of both depression and chronic
stress.
46–51 Our goal was to examine both the mono-
amine and stress hypotheses of depression, the former
by identifying the contribution of genes implicated by
the monoamine hypothesis to the two depression
model expression profiles, and the latter by defining
the overlap between the expression profiles of
endogenous depression and chronic stress response.
Our present results found no evidence for the
involvement of monoamine neurotransmission-
related genes in the expression profile of the
endogenous depression model and found divergent
expression profiles in endogenous depression and
chronic stress models. However, novel target genes
and pathways have emerged from this study, which
have the potential to advance our knowledge with
regard to the etiology of depression and its treatment.
Methods
Animal models
All procedures were approved by the Institutional
Animal Care and Use Committee of Northwestern
University. The WMI-WLI selective breeding com-
menced as described previously.
33 Animals showing
the most extreme FST behavior within each line were
selected for breeding, specifically avoiding sibling
mating until the G5 generation. Adult WMI and WLI
male animals from the 13th generation of selective
breeding were employed in this study. The experi-
mental design included daily administration of
desipramine (10mgkg
 1) or saline, subcutaneously
for 14 days, to both WMI and WLI animals (n=9 per
treatment per strain). Animals were killed by fast
decapitation on the 15th day immediately after
removal from the home cage.
For the CRS experiment, adult male Fischer 344
(F344), Brown-Norway (BN), Lewis (LEW) and WKY
rats were obtained from Harlan Laboratories (India-
napolis, IN, USA) (n=9 per strain per treatment). Rats
were either exposed to CRS in a breathable decap-
icone for 2h per day for a 2-week period or remained
in their home cage (no stress, NS). Body weight was
monitored throughout the experiment. On the 15th
day, both groups of rats were tested in the elevated
plus maze test in parallel and killed by decapitation
immediately following the 5-min test. Animals were
B100 days old at the time of sample collections.
Blood samples were collected for the determination of
plasma corticosterone (CORT) levels and adrenal
weight was also determined. The elevated plus maze
test of anxiety was used as a confirmation of strain
differences in anxiety measures basally (NS group)
and after CRS: the results are not shown since the
purpose of this study is to identify chronic stress-
induced changes in gene expression independently of
strain effects.
Behavioral testing
FST was performed as described previously.
30,52
Briefly, on day 1, rats were individually placed in
the water tank (water temperature 22–241C) for
15min. After 24h, rats were once again placed in
the tank for a 5-min test session. The test session was
videotaped and scored by a trained observer, using
the scoring system developed by Detke et al.
53 The
open-field test was performed as described pre-
viously,
54 but the animals’ movements were followed
and analyzed by the TSE Videomot 2 version 5.75
software.
Radioimmunoassay for plasma CORT
Assays were carried out in duplicate, as described
previously,
29 using the CORT RIA kit (MP Biomedi-
cals, Solon, OH, USA). The assay sensitivity was
2–4pg per tube. The intra- and interassay coefficients
of variation were 3.5 and 8%, respectively.
Microarray experiments
Brain regions were dissected immediately after
decapitation, as described previously,
55 and stored
at  801C in RNAlater (Ambion, Austin, TX, USA).
Individual hippocampi and amygdalae were homo-
genized in TRIzol (Invitrogen, Carlsbad, CA, USA),
and RNA was isolated following the manufacturer’s
protocol. All RNA samples were treated with DNase1
(Qiagen, Valencia, CA, USA) according to the manu-
facturer’s methods.
Total RNA isolated from WMI and WLI brain
regions was reverse-transcribed, and-double stranded
cDNA was synthesized with the GeneChip
s Expres-
sion 3-Amplification One-cycle kit (Affymetrix, Santa
Clara, CA, USA. In an in vitro reaction with T7 RNA
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labeled with biotinylated nucleotides (Affymetrix).
Ten micrograms of biotin-labeled and fragmented
cRNA was then hybridized onto Rat Genome 230 2.0
GeneChip arrays (Affymetrix).
Total RNA from the chronic stress experiment was
reverse transcribed, followed by second-strand cDNA
synthesis. For each sample, an in vitro transcription
reaction was carried out incorporating biotinylated
nucleotides according to the manufacturer’s protocol
for Illumina
s Totalprep RNA amplification kit
(Ambion). Biotin-labeled cRNA, 1.5mg, was then
hybridized onto RatRef-12 Expression BeadChips
(Illumina, San Diego, CA, USA).
Statistical analysis for WMI-WLI experiment
Probe intensity data from Rat 230v2 Affymetrix
GeneChip arrays were read into the R software
environment (http://www.R-project.org) directly from
CEL files using the R/affy package.
56 Affymetrix data
was normalized using the robust multiarray average
method for probe set data.
57 Data quality was assessed
using histograms of signal intensities, scatter plots
and hierarchical clustering of samples.
Analysis of variance (ANOVA) methods, performed
with the R/maanova package,
58,59 were used to
statistically resolve gene expression differences. The
experimental design included chronic administration
of desipramine or saline to both WMI and WLI
animals, of which three animals per strain per
treatment were randomly selected for the microarray
analyses. As we were only interested in the strain
effect in this experiment, treatment (desipramine or
saline) was a covariate. For each probe set g, strain i,
covariate j and replicate k, a linear model for the log-
transformed expression measure, yijkg, can be formu-
lated as a sum of components that contribute to the
overall intensity value:
yijkg ¼ mg þ aig þ bjg þð abÞijg þ eijkg ð1Þ
where mg is the mean intensity over all 12 samples, aig
is the effect of strain i (i=1, 2), bjg is the additive effect
of covariate j (j=1, 2), (ab)ijg is the interaction effect of
strain i, covariate j and probe set g and eijkg is the
residual error for strain i, covariate j, replicate k and
probe set g, respectively. To identify transcripts with a
high probability of being differentially expressed
between strains, statistical tests for the null hypoth-
esis H0: aig=0 vs the alternative H0: aiga0 were
performed. We excluded transcripts in which the
strain effect was not consistent between different
covariate levels, as identified by a statistical test for
the null hypothesis H0:( ab)ijg=0 vs the alternative H0:
(ab)ijga0. Both these tests were performed using Fs, a
modified F statistic incorporating shrinkage estimates
of residual variance.
60 P-values were calculated by
permuting model residuals 1000 times. Unless other-
wise noted, transcripts with differences between
strains were identified as those with P-values, or
estimated false-positive rates, less than 0.01 for the
hypothesis H0: aig=0 and greater than 0.01 for the
hypothesis H0:( ab)ijg=0. As an adjustment for multi-
ple testing, we used the q-value transformation of the
P-values to estimate false discovery rate.
61 To relate
probe sets to genes, probe set IDs were mapped to
symbols using NetAffx (http://www.affymetrix.com/
analysis/netaffx/). When reporting fold changes, we
consider WLI to be the reference strain. If the
measured expression level is higher in the WMI
strain than in the WLI strain, the fold change is
positive, and if it is lower in WMI than in WLI, the
fold change is negative.
For each experiment, we also applied models of
combined data from both tissues to measure the
differences in transcript abundance between tissue.
We used the model
yijklg ¼ mmg þ aig þ bjg þð abÞijg þ gkg þ eijklg ð2Þ
which is equivalent to model (1), except that there is
an additional variable (gkg) for tissue with indices
k=1,2 for the amygdala and hippocampus. Because
we applied the normalization separately by tissue, we
mean centered the normalized samples before apply-
ing this model.
Statistical analysis for stress experiment
Probe intensity data from Illumina Chip arrays were
read directly into the R software environment from
bead summary files produced by BeadStudio using
the R/beadarray package.
62 Quantile normalization
was applied to the Illumina bead summary data using
the R/preprocessCore package.
63 Data quality was
assessed as described for the WMI-WLI experiment.
Analysis of variance methods were similarly applied
for this experiment. Twelve rats were exposed to
chronic stress conditions, and 12 rats were not
exposed to chronic stress. The animals for each stress
condition consisted of three rats each from four
different strains (BN-SS, F344, LEW and WKY). The
linear model of equation (1) was applied for each probe
set g. In this case, aig, is the effect of condition i (i=1,2),
bjg is the additive effect of strain j (j=1, 2, 3, 4), which
is a covariate. To identify transcripts exhibiting
consistent differential expression owing to condition
across strains, we performed and applied statistical
tests for the null hypotheses H0: aig=0 vs H0: aiga0
and H0:( ab)ijg=0v sH 0:( ab)ijga0 that are analogous to
those described above for the WLI-WMI comparison.
Probe set IDs were mapped to symbols using Illumina’s
annotation resource (http://www.illumina.com/
support/annotation_files.ilmn). When reporting fold
changes, we consider the NS to be the reference
condition. If the measured expression in the CRS
condition is greater than in the NS condition, the fold
change is positive. If it is less under CRS than under
NS, the fold change is negative. To facilitate across-
experiment comparison by gene, probes were mapped
to gene symbols using current probe annotation files
provided by the array manufacturers. The suffixes
‘_predicted’ and ‘_mapped’ were truncated from the Illu-
mina symbol assignments. Where there were multiple
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statistic for the relevant hypothesis test were chosen
to give a one-to-one mapping across experiments for
10112 genes. The linear model of equation (2) was
applied analogously for this experiment to obtain the
distribution of estimated tissue effects.
Real-time RT-PCR
Real-time reverse transcription-polymerase chain
reaction (RT-PCR) was used to confirm microarray
results for a subset of randomly selected genes from
those fulfilling the criteria of significant (P<0.01)
expression differences. Reverse transcription for 2mg
of each sample was performed with Invitrogen’s
Superscript
s III First-Strand kit (18080-051) according
to the manufacturer’s protocol. Primers were designed
to amplify 80–150bp regions and to contain a
maximum amount of microarray probe sequence using
default settings of ABI’s Primer Express software
(version 3.0, PE Applied Biosystems, Carlsbad, CA,
USA). Primer sequences are listed in Supplementary
Table S1. Forty nanograms of cDNA was amplified in
20ml reactions (1  SYBR green reaction mix (ABI,
Carlsbad, CA, USA), 250mM primers) in the ABI
7900HT PCR machine using the relative quantification
(–ddCt) method, with 18s RNA as the internal control.
Results
Selective breeding and characterization of WMI and
WLI strains
The WMI and WLI rat strains consistently maintained
significant, dichotomous FST phenotypes throughout
21 generations of selective breeding (Figure 1a), with
WMIs always exhibiting greater immobility scores
than WLIs. In the open-field test of exploration/
anxiety, WMI and WLI male animals showed similar
level of exploration of the inner circle (Figure 1b),
suggesting no differences in anxiety-related beha-
viors. In contrast, WMIs explored the arena signifi-
cantly less than WLIs (Figure 1c), and the activity
traces (Figure 1d) illustrate freezing-like behavior
exhibited by the WMIs, a behavioral pattern very
similarly to psychomotor retardation. There were no
differences in the two strains’ basal plasma thyroxine
and CORT levels or their CORT responses to acute
restraint stress (Supplementary Table S2). Further-
more, no additional behavioral differences were
observed between the two strains, including anxiety-
like behaviors as assessed by the elevated plus maze
and defensive burying tests, confirming the results of
the open-field test, and spatial learning and memory
as measured in the Morris water maze (Supplemen-
tary Table S2). These data verify that the behavioral
differences between the two substrains of WKYs are
not fear or anxiety driven, but rather related to
depressive state.
CRS decreased body weight gain, increased plasma
CORT levels and adrenal weight
Genetic polymorphisms between the strains range
from 25.9% between F344 and LEW to 66% between
BN and WKY, representing a substantial interstrain
variation. However, CRS affected all strain of rats.
Specifically, CRS resulted in a lower body weight gain
compared with NS rats (F[1,65]=212.9, P<0.001), but
40
400 3000
2000
1000
0
200
0
WLI
NS
BN F344 LEW WKY BN F344 LEW WKY
CRS NS CRS
WMI WLI WMI
WLI WMI
WLI WMI
**
**
**
**
*
* *
*
a
ef
b
d
c
35
30
25
20
I
m
m
o
b
i
l
i
t
y
 
(
b
i
n
s
)
C
o
r
t
i
c
o
s
t
e
r
o
n
e
 
(
n
g
/
m
l
)
T
i
m
e
 
(
s
)
D
i
s
t
a
n
c
e
 
(
c
m
)
15
10
5
0
400
300
200
100
0
N
o
r
m
a
l
i
z
e
d
 
w
e
i
g
h
t
 
(
u
g
/
g
 
B
W
)
400
300
200
100
0
9 9 13 13 17 17 21 21
Figure 1 The endogenous depression model, the Wistar–Kyoto More Immobile (WMI) strain, shows depressive behavior not
linked to fear/anxiety (a–d). Chronic restraint stress (CRS) increases adrenocortical function consistently in all four strains
(e and f). (a) In the forced swim test (FST), immobility scores of the WMI and WKY Less Immobile (WLI) animals differ
significantly across generations. (b) Time spent in the inner circle of the open-field test, (c) total distance traveled and (d)
movement traces of representative WMI and WLI animals. (e) Plasma corticosterone levels were consistently elevated after
CRS in all four strains and (f) adrenal weights were consistently greater in the CRS group of all strains. *P<0.01, **P<0.001.
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paradigm (body weight on day 1: 239±5g; on day 14
of CRS: 244±5g). Plasma CORT levels were elevated
in all rats exposed to the chronic stress procedure
compared with those not subjected to stress (Figure
1e; strain: (F[1,65]=105.37, P<0.001) and those
subjected to stress (F[3,65]=6.75, P<0.001; strain,
stress interaction NS). As expected, chronic stress
increased adrenal weight in all four rat strains (Figure
1f; strain: F[3,41]=1.34, NS; stress: F[1,41]=4.77,
P=0.035). Taken together, these data established that
all CRS rats were undergoing expected physiological
changes associated with CRS exposure.
Differential gene expression profile in the amygdala
and hippocampus of WMI and WLI male rats
Six hundred and thirty-eight genes in the amygdala
and 463 in the hippocampus were differentially
expressed between the WMI and WLI animals
(P<0.01). Genes that additionally had fold changes
above 1.4 (40% increase or decrease) are listed in
Table 1. The complete data set is shown in Supple-
mentary Tables S3 (amygdala) and S4 (hippocampus).
Twenty-seven genes were differentially expressed in
both brain regions between WMI and WLI in the same
direction.
Gene expression changes in response to chronic stress
in the amygdala and hippocampus of four strains of
male rats
To eliminate strain-specific effects in our selection
attributable to differences in stress reactivity or
potential cognitive differences between strains, genes
were selected based on consistent, significant expres-
sion level differences in all four strains. We found
125 genes in the amygdala and 126 genes in the
hippocampus that were differentially expressed
between the CRS and NS conditions (P<0.01)
(Supplementary Tables S5 and S6). From these, the
10 amygdalar and hippocampal genes with absolute
fold changes above 1.4 are shown in Table 1. Twelve
of the genes showed the same directional changes in
both brain regions.
Minimal overlap between depression and stress
response
Both the WMI-WLI and CRS-NS gene sets were
examined for brain region-specific overlap using all
known aliases to account for possible differences
between microarray platform target nomenclatures.
Only two genes in the amygdala (Kcnj14 and Mprl9)
and four in the hippocampus (Chi3l1, collagen type I
alpha 1 (Col1a1), matrix metallopeptidase 14
(Mmp14) and RGD1305680) showed differential ex-
pression in both the chronic stress response and
endogenous depression comparisons. On the basis of
the stress hypothesis of depression, transcripts
with lowered expression levels in WMI animals
should show similarly decreased expression in CRS
animals, and increased expression in WMIs should
correspond to increased expression in CRS. When we
examined the directionality of fold changes for the six
overlapping genes, only three genes (Col1a1, Mmp14
and RGD1305680), all in hippocampal tissue, showed
these hypothesized directional changes. This pro-
vides suggestive evidence that the molecular signa-
ture of chronic stress and endogenous depressive
behavior in these brain regions are not similar.
However, since comparison of overlap between small
sets of selected genes can be sensitive to thresholding,
we also compared the differences between model
effects for CRS and NS with the differences for WMI
and WLI.
Expression differences in both models were rela-
tively small (Figures 2a and b). If there is an under-
lying relationship between expression differences in
response to CRS and endogenous depressive behavior
for many genes, we should see significant positive
correlation between the differences in gene expres-
sion across the two experiments. In particular, the
differences between WMI and WLI model effects
and differences between CRS and NS model effects
((a2g a1g) in equation (1)) should show positive
correlation. The Spearman’s correlation (r) for these
comparisons of differences were not significantly
different than zero in either tissue (r= 0.12, amyg-
dala; r= 0.02, hippocampus; Figures 2a and b). This
lack of observed correlation could be explained by the
different platforms or by the chronologies of the
experiments. To address this concern, equation (2),
which combined data of both brain regions and
estimates the tissue effects, was employed. The tissue
(interbrain region) effects showed significant positive
correlation between experiments (r=0.48, P<0.001;
Figure 2c). We also measured correlation for the
subset of genes for which the magnitude of tissue
effects were comparable to the CRS-NS and WMI-WLI
effects, specifically those having a magnitude below
0.4 on both platforms. Within this subset, we still
found significant positive correlation (r=0.31,
P<0.001). We conclude that we should have observed
correlation between the CRS-NS and WMI-WLI effects
if it were present despite the platform differences.
This suggests that, on a global scale, the effects of
chronic stress and endogenous depression on the
amygdalar and hippocampal transcriptome are dis-
similar.
Confirmation of the expression differences by real-time
RT-PCR
We carried out quantitative RT-PCR confirmation of
the microarray data using total RNA samples from
both experiments and primer pairs described in
Supplementary Table S1. Pearson’s correlation of fold
change from the Affymetrix microarray for 16 genes
with relative quantification ratios from qPCR (RQ
ratio) showed significant concurrence of data
(r=0.720, P=0.002; Figure 3a). Pearson’s correlation
of fold change from the Illumina microarray for nine
genes (three were confirmed in both brain regions)
with relative quantification ratios from qPCR showed
similarly significant correlation (r=0.725, P=0.008;
Gene expression patterns in the hippocampus and amygdala
BM Andrus et al
53
Molecular PsychiatryTable 1 Differentially expressed depression genes (top) and stress genes (bottom) in the amygdala and hippocampus
Probe set Gene name Rat/human
symbol
Cytoband Fold
change
P-value
Amygdala
1370215_at Complement component 1, q subcomponent, beta polypeptide C1qb/C1QB 5q36  1.60 9.96E 03
1376198_at Adipocyte-specific adhesion molecule Asam/ASAM 8q22  1.60 9.55E 06
1380497_at Ash1 (absent, small or homeotic)-like (Drosophila) Ash1l/ASH1L 2q34 1.58 1.84E 04
1390835_at Solute carrier family 47, member 1 Slc47a1/
SLC47A1
10q22–
q23
 1.55 5.16E 04
1387029_at Complement factor H Cfh/CFH 13q13  1.54 2.26E 03
1378518_at Ewing sarcoma breakpoint region 1 Ewsr1/EWSR1 14q21 1.54 8.50E 05
1394940_at Family with sequence similarity 46, member A Fam46a/
FAM46A
8q31  1.53 3.78E 03
1398522_at Ankyrin repeat and LEM domain containing 2 Ankle2/
ANKLE2
12q16 1.50 8.22E 06
1379917_at Adaptor-related protein complex 3, sigma 1 subunit Ap3s1 /AP3S1 18q11  1.49 3.11E 03
1379264_at Zinc- and ring finger 1 Znrf1/ZNRF1 4q24  1.49 7.88E 04
1376175_at Glioblastoma amplified sequence Gbas/GBAS 12q13 1.48 1.47E 03
1394964_at BAT2 domain containing 1 Bat2d1/BAT2D1 13q22 1.48 8.48E 06
1370989_at Ret proto-oncogene Ret/RET 4q42  1.47 1.15E 03
1367749_at Lumican Lum/LUM 7q13  1.46 5.74E 03
1394814_at Translocated promoter region Tpr/TPR 13q21 1.46 2.37E 04
1383997_at Mitogen-activated protein kinase 1 Mapk1/MAPK1 11q23  1.45 3.46E 04
1391524_at Similar to WD repeat domain 11 protein RGD1564964/
PHIP
8q31 1.44 5.17E 05
1369742_at Hect (homologous to the E6-AP (UBE3A) carboxyl-terminus)
domain and RCC1 (CHC1)-like domain (RLD) 1
Herc1/HERC1 8q24 1.44 4.21E 04
1385101_a_at Coiled-coil domain containing 127 Ccdc127/
CCDC127
1p11 1.43 9.94E 05
1391788_at Sin3-associated polypeptide, 18kDa Sap18/SAP18 15p12 1.43 6.33E 04
1378520_at B-cell CLL/lymphoma 11B (zinc-finger protein) Bcl11b/BCL11B 6q32 1.42 2.68E 04
1390112_at EGF-containing fibulin-like extracellular matrix protein 1 Efemp1/
EFEMP1
14q22  1.42 2.45E 04
1384000_at SRY (sex determining region Y)-box 4 Sox4/SOX4 17p12 1.42 6.48E 03
1370891_at Cd48 molecule Cd48/CD48 13q24  1.41 8.88E 03
1381829_at Zinc-finger protein 318 Zfp318/ZNF318 9q12 1.41 3.40E 03
1370122_at RAB27B, member RAS oncogene family Rab27b/
RAB27B
18q12.1 1.40 6.89E 04
1380569_at Ring finger protein 41 Rnf41/RNF41 7q11  1.40 7.40E 05
Hippocampus
1392948_at Chloride intracellular channel 6 Clic6/CLIC6 11q11  3.35 4.25E 05
1379281_at Sclerostin domain containing 1 Sostdc1/
SOSTDC1
6q16  3.30 2.20E 05
1374320_at Coagulation factor V (proaccelerin, labile factor) F5/F5 13q22  3.12 1.04E 04
1378365_at Solute carrier family 4, sodium bicarbonate cotransporter,
member 5
Slc4a5/SLC4A5 4q34  2.83 1.39E 04
1370384_a_at Prolactin receptor Prlr/PRLR 2q16  2.61 2.09E 04
1367598_at Transthyretin Ttr/TTR 18p  2.60 5.93E 03
1377434_at Membrane frizzled-related protein Mfrp/MFRP 8q22  2.55 2.20E 04
1375465_at Orthodenticle homolog 2 (Drosophila) Otx2/OTX2 15p14  2.52 4.78E 05
1376944_at Prolactin receptor Prlr/PRLR 2q16  2.25 4.54E 04
1382083_at Coagulation factor C homolog, cochlin (Limulus polyphemus) Coch/COCH 6q22  1.80 8.12E 06
1368606_at Solute carrier organic anion transporter family, member 1a5 Slco1a5/
SLCO1A2
4q44  1.79 1.01E 03
1372299_at Cyclin-dependent kinase inhibitor 1C (P57) Cdkn1c/
CDKN1C
1q42  1.77 2.67E 05
1367700_at Fibromodulin Fmod/FMOD 13q13  1.70 1.16E 05
1371849_at 50-Nucleotidase domain containing 2 Nt5dc2/
NT5DC2
16p16  1.63 2.72E 04
1369625_at Aquaporin 1 Aqp1/AQP1 4q24  1.61 1.29E 03
1367682_at Midkine Mdk/MDK 3q24  1.61 5.17E 04
1368536_at Ectonucleotide pyrophosphatase/phosphodiesterase 2 Enpp2/ENPP2 7q31  1.60 3.55E 04
1391211_at Atpase, class VI, type 11C Atp11c/ATP11C Xq36  1.58 1.36E 03
Gene expression patterns in the hippocampus and amygdala
BM Andrus et al
54
Molecular PsychiatryFigure 3b). Positive and negative fold changes are
defined in Methods.
When we examined the validated transcript fold
change in the microarrays in relation to their
respective P-value, we found no significant correla-
tion (r=0.113, P>0.05; Figure 3c). These data confirm
that significance and fold change criteria cannot be
used interchangeably, but that expression changes
can be confirmed by real-time RT-PCR, even if the fold
change is small.
The molecular pathways of depression and stress
response genes
The lists of hippocampal and amygdalar genes with
significant expression differences were combined into
single gene lists for each of our two models, and the
rat gene symbols were converted to their human
orthologs to access a larger body of literature. These
master ortholog lists were subjected to functional
annotation using the PANTHER Classification Sys-
tem.
64 In addition, we used the PANTHER binomial
statistics tool to compare our annotated ortholog lists
to the NCBI Homo sapiens reference gene list to
determine significant over- or under-representation of
molecular function, biological process or pathway
classification terms.
65
Table 2 shows significantly over- and under-
represented terms from both gene sets. A group of
genes identified to belong to the integrin signaling
pathway (including Araf, Arf1, Arf4, Arhgap10,
Col12a1, Col15a1, Col1a1, Col4a1, Col5a2, Col6a6,
Crkl, Elmo1, Fnlb, Grb2, Itga11, Itga6, Itgae, Itgb6,
Itgb8, Itgbl1, Mapk1, Pik3r1, Pitk2b, Rac1, Rhoa and
Tln2) were most overly represented in the WMI-WLI
comparison. From the CRS-NS comparison, the
Huntington disease pathway showed the only sig-
nificantly clustered group of genes (Capn9, Gapdh,
Rhog, Tnfaip8, Tnfaip8l3 and tumor suppressor
protein 53).
The biological process terms ‘Cellular Process’,
‘Cell Communication’ and ‘Signal Transduction’ were
significantly over-represented in both the CRS-NS
and the WMI-WLI gene lists. It is of further interest
that metabolic process terms are the most over-
represented in the WMI-WLI comparison, while
cellular process terms, mainly immune system-
related, are over-represented in the CRS-NS gene list.
There was no overlap in over- or under-represented
molecular function terms between the stress response
and endogenous depression gene lists.
Discussion
This study identified novel molecular signatures
of chronic stress and of endogenous depressive
behavior in animal models. However, absence of
Table 1 Continued
Probe set Gene name Rat/human
symbol
Cytoband Fold
change
P-value
1376728_at Hypothetical RNA binding protein RGD1359713 RGD1359713/
RBM47
14p11  1.55 1.24E 03
1375026_at Calmodulin-like 4 Calml4/
CALML4
8q24  1.54 1.40E 03
1387791_at Angiotensin I-converting enzyme (peptidyl-dipeptidase A) 1 Ace/ACE 10q32.1  1.49 5.35E 03
1368046_at Solute carrier family 31 (copper transporters), member 1 Slc31a1/
SLC31A1
5q24  1.49 3.36E 03
1370068_at Phospholipase A2, group V Pla2g5/PLA2G5 5q36  1.48 3.94E 03
1376285_at GULP, engulfment adaptor PTB domain containing 1 Gulp1/GULP1 9q22  1.48 6.20E 03
1386770_x_at Potassium voltage-gated channel, Isk-related subfamily, gene 2 Kcne2/KCNE2 11q11  1.48 1.69E 03
1374139_at Cerebellar degeneration-related 2 Cdr2/CDR2 1q35-q36  1.46 5.40E 04
1368202_a_at Disabled homolog 2, mitogen-responsive phosphoprotein
(Drosophila)
Dab2/DAB2 2q16  1.44 2.68E 05
1369798_at ATPase, Na
þ/K
þ transporting, beta 2 polypeptide Atp1b2/ATP1B2 10q24  1.42 5.24E 03
Amygdala
4610273 Hemoglobin, beta MGC72973/HBB 1q32  1.61 1.91E 03
3140088 Ribosomal protein L30 Rpl30/RPL30 7q22  1.58 2.07E 03
6650278 Hemoglobin alpha, adult chain 2 Hba-a2/HBA1 10q12  1.57 1.93E 06
4210725 Transthyretin (prealbumin, amyloidosis type I) Ttr/TTR 18p12  1.55 3.47E 03
2510524 Hemoglobin, beta Hbb/HBB 1q32  1.53 1.93E -06
Hippocampus
6650278 Hemoglobin alpha, adult chain 2 Hba-a2/HBA1 10q12  1.80 2.90E 06
4780059 Insulin-like growth factor 2 (somatomedin A) Igf2/IGF2 1q41  1.79 7.16E 05
2510524 Hemoglobin, beta Hbb/HBB 1q32  1.75 4.84E 06
4610273 Hemoglobin, beta MGC72973/HBB 1q32  1.64 9.67E 05
3840156 Collagen, type I, alpha 2 Col1a2/COL1A2 4q13  1.46 5.32E 03
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files suggests that independent molecular mechan-
isms regulate these two states.
Among genes showing significantly altered tran-
scription levels in the amygdala and hippocampus in
the endogenous depression model, there was a
complete omission of serotoninergic, adrenergic and
dopaminergic neurotransmission-related genes. This
finding, although surprising, is congruent with gene
expression studies of human postmortem MDD
brains.
66–68 We did find that multiple newer anti-
depressant targets, including Grm5,
69 and a number of
phosphodiesterases,
70 were differentially expressed
between WMIs and WLIs. In addition to these
previously described targets, we identified several
novel depressive behavior-related genes and path-
ways. Physiologically intriguing findings include the
decreased mRNA levels of prolactin receptor and
angiotensin I-converting enzyme in the WMI hippo-
campus; these genes have known peripheral function,
but they have not been associated with depressive
behavior as yet. Other intriguing examples of novel
implications for endogenous depression include the
solute carrier family 4, sodium bicarbonate co-
transporter and member 5 gene (Slc4a5), which has
recently been associated with metabolic pheno-
types.
71 Interestingly, metabolic processes were the
most over-represented biological process terms in the
WMI-WLI gene ontology. The integrin signaling path-
way, which was over-represented in the endogenous
depression gene set, contains different members of
the collagen family, some of which are also implicated
in the chronic stress response. Finally, mRNA
levels of dehydrodolichyl diphosphate synthase are
increased in both the hippocampus and the amygdala
of WMI. Dehydrodolichyl diphosphate synthase is
responsible for synthesizing dolichol, which accu-
mulates in the neuropathological human brain.
72
The set of genes whose hippocampal or amygdalar
expression patterns were altered by chronic stress in
all four rat strains represent a generalizable molecular
response to chronic stress. Many of these genes have
shown matching directional changes by unpredict-
able chronic mild stress, and these include: Col1a1,
tissue plasminogen activator, insulin-like growth
factor binding protein 2, amyloid beta precursor
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Figure 2 An across-experiment, gene-to-gene mapping was created for 10112 gene symbols. Scatter plots are shown for
observed effects obtained from the chronic restraint stress-no stress (CRS-NS) microarray experiment (vertical axis) and the
Wistar–Kyoto More Immobile-WKY Less Immobile (WMI-WLI) microarray experiment (horizontal axis) by applying the
linear models of Equation (1) and (2). The statistics are differences in condition effects, a2g a1g, for the amygdala (a) and
hippocampus (b), and differences in brain region-related effects, g2g g1g (c).
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Figure 3 (a) Validation of genes differentially expressed in Wistar–Kyoto More Immobile (WMI) and WKY Less Immobile
(WLI) hippocampi or amygdala (n=6 per strain) by real-time reverse transcription-polymerase chain reaction (RT-PCR). The
correlation between fold change in the Affymetrix microarray experiment and real-time RT-PCR determination of relative
quantification ratios are shown (Pearson’s correlation, r=0.720, P=0.002). (b) Validation of genes differentially expressed in
chronic restraint stress (CRS) vs no stress (NS) (n=12 per treatment) hippocampi or amygdala by real-time RT-PCR. The
correlation between fold change in the Illumina array experiment and real-time RT-PCR determination of relative
quantification ratios are shown (Pearson’s correlation, r=0.725, P=0.008). (c) Lack of correlation between absolute fold
change and significant P-value (–logP) from the microarray analyses for genes with expression changes validated by real-time
RT-PCR.
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Molecular PsychiatryTable 2 Over- and under-represented gene ontology (GO) groups determined by the Panther software analysis
NCBI
(19911)
a
STR
(206)
b
EXP þ/  P-value DEP
(1065)
c
EXP þ/  P-value
Pathway
Huntington disease 167 6 1.73 þ 8.30E 03 10 9 þ 4.04E 01
Integrin signaling pathway 189 3 1.96 þ 3.11E 01 26 10 þ 1.88E 05
Ras pathway 79 0 0.82   4.41E 01 14 4 þ 1.28E 04
Heterotrimeric G-protein signaling pathway–
Gq alpha- and Go alpha-mediated pathway
134 0 1.39   2.49E 01 16 7 þ 2.91E 03
Angiogenesis 191 0 1.98   1.37E 01 19 10 þ 8.55E 03
Axon guidance mediated by semaphorins 43 1 0.44 þ 3.59E 01 7 2 þ 9.28E 03
Biological process
Primary metabolic process 7959 95 82.34 þ 4.26E 02 533 426 þ 1.88E 11
Metabolic process 8276 101 85.62 þ 1.82E 02 548 443 þ 4.98E 11
Cellular process 6309 83 65.27 þ 5.60E 03 433 337 þ 4.35E 10
Cell communication 4408 65 45.61 þ 1.13E 03 313 236 þ 2.13E 08
Protein metabolic process 3247 41 33.59 þ 9.86E 02 240 174 þ 8.45E 08
Signal transduction 4234 61 43.81 þ 3.02E 03 296 226 þ 2.73E 07
Transport 2857 42 29.56 þ 1.13E 02 213 153 þ 3.10E 07
Neurological system process 1995 29 20.64 þ 3.89E 02 152 107 þ 7.07E 06
Vesicle-mediated transport 1160 13 12 þ 4.24E 01 98 62 þ 7.86E 06
Intracellular signaling cascade 1609 17 16.65 þ 5.01E 01 127 86 þ 9.00E 06
System process 2264 33 23.42 þ 2.73E 02 167 121 þ 1.41E 05
Endocytosis 575 8 5.95 þ 2.47E 01 56 31 þ 2.03E 05
Nucleobase, nucleoside, nucleotide and
nucleic acid metabolic process
3827 39 39.59   5.01E 01 257 205 þ 4.43E 05
Synaptic transmission 635 10 6.57 þ 1.25E 01 59 34 þ 4.53E 05
Protein transport 1646 18 17.03 þ 4.39E 01 124 88 þ 8.73E 05
Intracellular protein transport 1646 18 17.03 þ 4.39E 01 124 88 þ 8.73E 05
Cellular amino-acid and derivative metabolic
process
367 3 3.8   4.73E 01 38 20 þ 1.29E 04
Amino-acid transport 77 1 0.8 þ 5.50E 01 13 4 þ 3.47E 04
Carbohydrate metabolic process 952 17 9.85 þ 2.10E 02 76 51 þ 4.44E 04
Cell–cell signaling 1374 22 14.22 þ 2.82E 02 102 73 þ 6.19E 04
Developmental process 3052 40 31.58 þ 6.60E 02 202 163 þ 7.65E 04
Cellular component organization 1492 18 15.44 þ 2.84E 01 108 80 þ 1.00E 03
Response to stress 500 9 5.17 þ 7.74E 02 44 27 þ 1.18E 03
Mitosis 635 7 6.57 þ 4.86E 01 52 34 þ 2.04E 03
Vitamin transport 95 2 0.98 þ 2.58E 01 13 5 þ 2.25E 03
Ectoderm development 1469 24 15.2 þ 1.81E 02 104 79 þ 2.46E 03
Lipid metabolic process 1119 14 11.58 þ 2.70E 01 82 60 þ 2.92E 03
Cell cycle 1882 20 19.47 þ 4.84E 01 128 101 þ 3.23E 03
Cellular component morphogenesis 1170 15 12.1 þ 2.32E 01 84 63 þ 4.42E 03
Anatomical structure morphogenesis 1170 15 12.1 þ 2.32E 01 84 63 þ 4.42E 03
Visual perception 412 5 4.26 þ 4.23E 01 35 22 þ 6.00E 03
Carbohydrate transport 187 6 1.93 þ 1.39E 02 19 10 þ 6.94E 03
Cell surface receptor linked signal
transduction
2235 33 23.12 þ 2.32E 02 146 120 þ 6.98E 03
Response to stimulus 1798 34 18.6 þ 4.49E 04 113 96 þ 4.29E 02
Immune system process 2630 43 27.21 þ 1.50E 03 156 141 þ 9.12E 02
Immune response 756 16 7.82 þ 5.73E 03 40 40   5.14E 01
Macrophage activation 305 9 3.16 þ 4.86E 03 16 16   5.35E 01
Molecular function
Binding 6794 76 70.29 þ 2.21E 01 467 363 þ 3.01E 11
Protein binding 3200 36 33.11 þ 3.19E 01 247 171 þ 1.10E 09
Catalytic activity 5336 65 55.21 þ 7.36E 02 363 285 þ 9.65E 08
Transporter activity 942 11 9.75 þ 3.84E 01 87 50 þ 9.21E 07
Enzyme regulator activity 1187 9 12.28   2.11E 01 103 63 þ 1.46E 06
Transmembrane transporter activity 897 11 9.28 þ 3.26E 01 81 48 þ 5.02E 06
Transferase activity 1593 16 16.48   5.16E 01 121 85 þ 7.65E 05
Kinase regulator activity 320 0 3.31   3.55E 02 35 17 þ 8.46E 05
Translation factor activity, nucleic acid binding 107 0 1.11   3.30E 01 17 6 þ 9.55E 05
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hippocampus.
39,73 In addition, stress has previously
been found to increase the expression of amyloid beta
precursor protein
74,75 and neuropeptide Y.
76–78 Our
findings, however, also implicate a number of novel
‘stress genes’. Among these, the decreased mRNA
levels of tumor suppressor protein 53, insulin-like
growth factor 2 and hemoglobin beta and alpha a1 are
of particular interest. Tumor suppressor protein 53
has been linked to the pathology of Huntington
disease,
79 a finding that is connected to the over-
representation of our chronic stress response genes
involved in the Huntington pathway. Insulin-like
growth factor 2 is an imprinted gene, described as
having both neuroprotective and neurodegenerative
properties,
80 as well as involvement in metabolic
disorders. Recently, hemoglobin beta and alpha
transcripts and proteins have been found in cortical
and hippocampal astrocytes, mature oligodendro-
cytes and a subpopulation of dopaminergic neurons.
81
If the decreased expression of hemoglobin beta and
alpha a1 is a manifestation of chronic stress-induced
decreases in oxygen storage, these findings would
implicate chronic stress in neurodegenerative pro-
cesses. If, however, they are related to the neurotoxi-
city of hemoglobins,
82 the decreased expression of
hemoglobin beta and alpha a1 and of tumor suppres-
sor protein 53 would propose the heretical idea of
chronic stress being neuroprotective.
If depression in general is a result of chronic stress
and stress-related factors, these genes should be
shared with the endogenous ‘depression transcrip-
tome’, as defined by WMI-WLI differences. However,
a surprisingly small number of genes were shared
between WMI-WLI and NS-CRS differentially ex-
pressed genes in the amygdala and hippocampus.
Genes showing parallel directional expression
changes in the hippocampus between the ‘endogen-
ous depression’ and the ‘chronic stress’ gene sets
include: Col1a1, Mmp14 and RGD1305680 (homo-
logous to the KIAA0240 gene). Mmp14 (also known as
MT1-MMP) degrades endogenous beta amyloids
83 and
is implicated in the pathogenesis of central nervous
system inflammatory disorders. It is also a tethered
membrane collagenase, which, together with the
involvement of Col1a1, implies the significance
of extracellular matrix remodeling in depressive
behavior and chronic stress. Ontological analysis
further and more broadly confirmed the dissimilarity
between the endogenous depressive behavior and
generic stress response expression profiles. Func-
tional annotation of the genes involved in both
states revealed few common biological processes
and no common molecular functions between the
two gene sets.
This study using animal models contends that
endogenous depression and chronic stress response
are regulated by independent molecular pathways. In
humans, an inference of this finding would be that
stress-induced and endogenous subtypes of depres-
sion are etiologically distinct. There are both human
and animal studies supporting this assumption.
Table 2 Continued
NCBI
(19911)
a
STR
(206)
b
EXP þ/  P-value DEP
(1065)
c
EXP þ/  P-value
Translation initiation factor activity 80 0 0.83   4.36E 01 14 4 þ 1.46E 04
Nucleic acid binding 3863 43 39.97 þ 3.23E 01 253 207 þ 2.58E 04
Small GTPase regulator activity 495 4 5.12   4.17E 01 45 26 þ 5.46E 04
RNA binding 530 3 5.48   2.00E 01 47 28 þ 6.97E 04
Translation regulator activity 105 0 1.09   3.36E 01 15 6 þ 7.08E 04
Hydrolase activity 2236 34 23.13 þ 1.43E 02 154 120 þ 7.34E 04
Guanyl-nucleotide exchange factor activity 160 0 1.66   1.90E 01 19 9 þ 1.33E 03
Lipid transporter activity 92 0 0.95   3.85E 01 13 5 þ 1.71E 03
Receptor binding 1235 17 12.78 þ 1.42E 01 89 66 þ 3.11E 03
RNA splicing factor activity, transesterification
mechanism
268 1 2.77   2.34E 01 26 14 þ 3.31E 03
Helicase activity 159 1 1.65   5.10E 01 17 9 þ 6.43E 03
Kinase inhibitor activity 122 0 1.26   2.82E 01 14 7 þ 7.15E 03
Amino-acid transmembrane transporter
activity
98 0 1.01   3.62E 01 12 5 þ 7.60E 03
Deaminase activity 43 0 0.44   6.41E 01 7 2 þ 9.28E 03
Acyltransferase activity 193 0 2   1.34E 01 19 10 þ 9.46E 03
Extracellular matrix structural constituent 147 7 1.52 þ 9.41E 04 15 8 þ 1.47E 02
Abbreviations: DEP, depression genes; EXP, expected (rounded to nearest whole number); NCBI, National Center for
Biotechnology Information; STR, chronic stress response genes.
aTotal number of genes referenced from NCBI.
bStress response genes (P<0.01) per GO term out of 194 total.
cDepression genes (P<0.01) per GO term out of 998 total.
P<0.01 values are bolded.
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Molecular PsychiatryFor example, only a subset of depressive phenotypes
can be causally attributed to stressful life events, and
these phenotypes indicate only a moderately in-
creased risk of developing depression.
84,85 In addi-
tion, although the chronic mild stress model is
thought of as a model of depression, some animals
are resistant to the anhedonic effect of stress.
73,86–88
Similarly, some animals are resilient to learned
helplessness in the congenital learned helplessness
model of depression,
25,89 suggesting that differences
in vulnerability to stress may determine the develop-
ment of depressive phenotype in these models. Thus,
it is possible that stress-susceptible individuals
could develop a subtype of depression distinct from
endogenous depression; this subtype may show
greater comorbidity with other stress-related disor-
ders. The existence of different subtypes of depres-
sion is in further agreement with the findings of
Krishnan and Nestler,
84 which state that there is no
‘unified theory’ of depression. Should our findings
translate to MDD, they suggest that different treatment
strategies, dependent on the patient’s depressive
subtype, could be beneficial. Furthermore, as most
animal models of depression are based on stress, the
above findings predict that using various genetic
animal models of depression could lead to novel drug
targets that may achieve successful treatment of
patients in which current treatment methods fail.
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